Sign in
4

Changes in Ownership

X4 Pharmaceuticals, Inc Filed Acc 0001628280-25-040441

Executive Chairman acquired 289,881 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Craig Adam R Executive Chairman 2025-08-14 Grant or award +289,881 289,881 D
Derivatives
Craig Adam R Executive Chairman 2025-08-12 Grant or award · Stock Option (right to buy) +1,609,873 1,609,873 D
Craig Adam R Executive Chairman 2025-08-14 Grant or award · Stock Option (right to buy) +529,201 529,201 D
Loading xslF345X05/wk-form4_1755217877.xml…